Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts

被引:33
作者
Adachi, T
Hara, H
Yamada, H
Yamazaki, N
Yamamoto, M
Sugiyama, T
Futenma, A
Katagiri, Y
机构
[1] Gifu Pharmaceut Univ, Lab Clin Pharmaceut, Gifu 5028585, Japan
[2] Aichi Med Univ, Dept Internal Med 1, Aichi 4801195, Japan
[3] Gifu Univ Hosp, Dept Pharm, Gifu 5008705, Japan
关键词
extracellular-superoxide dismutase; heparin; nitric oxide; sulfation; fibroblasts;
D O I
10.1016/S0021-9150(01)00512-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extracellular-su peroxide dismutase (EC-SOD) is the major SOD isozyme in the arterial wall and may be important for antioxidation capability of the vascular wall and normal vascular function. EC-SOD is expressed in various cell types in the vascular wall such as fibroblasts, smooth muscle cells and macrophages, and the synthesis of EC-SOD by human fibroblasts is known to be highly responsive to various inflammatory cytokines, although there is no response to oxidative stress. Heparin is a highly sulfated glycosaminoglycan with many functions such as antithrombotic, antilipemic and antiatherosclerotic effects. Another less well-known function of heparin is regulation of protein synthesis. In this study, we measured the induction of EC-SOD after treatment with heparin to understand the role of heparin in the antiatherosclerotic response of fibroblasts. Heparin induced EC-SOD expression at both the mRNA and protein levels. Heparin showed the greatest stimulatory effect and heparan sulfate showed moderate effects. The effect of chondroitin sulfate A was not clear. In contrast, desulfated heparin and chondroitin sulfate C did not increase EC-SOD expression. The stimulatory effect seemed to increase roughly with the degree of glycosaminoglycan sulfation. The enhanced expression of EC-SOD by heparin must contribute to the antiatherosclerotic effect of heparin. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 42 条
[1]   NONENZYMATIC GLYCATION OF HUMAN EXTRACELLULAR SUPEROXIDE-DISMUTASE [J].
ADACHI, T ;
OHTA, H ;
HIRANO, K ;
HAYASHI, K ;
MARKLUND, SL .
BIOCHEMICAL JOURNAL, 1991, 279 :263-267
[2]   THE HEPARIN BINDING-SITE OF HUMAN EXTRACELLULAR-SUPEROXIDE DISMUTASE [J].
ADACHI, T ;
KODERA, T ;
OHTA, H ;
HAYASHI, K ;
HIRANO, K .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 297 (01) :155-161
[3]   Substitution of glycine for arginino-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface [J].
Adachi, T ;
Yamada, H ;
Yamada, Y ;
Morihara, N ;
Yamazaki, N ;
Murakami, T ;
Futenma, A ;
Kato, K ;
Hirano, K .
BIOCHEMICAL JOURNAL, 1996, 313 :235-239
[4]  
ADACHI T, 1989, J BIOL CHEM, V264, P8537
[5]  
Adachi T, 1998, BIOL PHARM BULL, V21, P1090
[6]  
ArroyoYanguas Y, 1997, J CELL BIOCHEM, V64, P595, DOI 10.1002/(SICI)1097-4644(19970315)64:4<595::AID-JCB8>3.0.CO
[7]  
2-M
[8]   ENDOTHELIUM-DEPENDENT INHIBITION OF PLATELET-AGGREGATION [J].
AZUMA, H ;
ISHIKAWA, M ;
SEKIZAKI, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (02) :411-415
[9]  
BJORNSSON TD, 1988, J PHARMACOL EXP THER, V245, P804
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3